The Novel Antibody Therapeutics Congress 2019 will feature talks on the discoveries and developments of antibody-based cancer therapies. The talks will review the recent developments in bispecific antibody technology, as well as the potential of new antibody and antibody-mimicking formats. A dedicated checkpoint blockades session will also examine new approaches in neutralizing cancer cell immune blockades, including advances in PD1, PD-L1, and CTLA4 targeting therapeutics, and the discovery and targeting of new biomarkers. As one of the dominant biologic formats, monoclonal antibodies stand ready to capitalize on this, building on two decades offered of exciting advancements in the treatment of cancer.
Along with this congress, get access to 100+ presentations in four other co-located meetings:
- Liquid Biopsies Congress
- Flow Cytometry Congress
- TMB & Neoantigen Congress
- Adoptive Cell Transfer Congress
Date: 10th-11th October 2019 | 9.00 am – 5.00 pm
Venue: London Heathrow Marriott Hotel, Bath Road Heathrow Airport, Hayes UB3 5AN
Website: http://www.global-engage.com/event/novel-antibody-congress/
For any inquiries, please contact:
Jane Williams | jane@globalengage.co.uk | (0)1865 849841
